I agree that this site is using cookies. You can find further informations here.
X
Toyozawa, Ryo
96  results:
Search for persons X
?
1

Clinical outcomes in patients with non-small cell lung canc..:

Okahisa, Masanobu ; Udagawa, Hibiki ; Matsumoto, Shingo...
Lung Cancer.  191 (2024)  - p. 107798 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Five Cases of Cytokine Release Syndrome in Patients Receivi..:

Shiraishi, Yoshimasa ; Tokito, Takaaki ; Toyozawa, Ryo...
Journal of Thoracic Oncology.  19 (2024)  2 - p. 337-343 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Phase 2 trial of crizotinib in Japanese patients with advan..:

Nosaki, Kaname ; Yoh, Kiyotaka ; Toyozawa, Ryo...
International Journal of Clinical Oncology.  29 (2024)  8 - p. 1142-1151 , 2024
Link: https://doi.org/10.1007/..
 
?
4

Docetaxel Plus Ramucirumab With Primary Prophylactic Pegyla..:

Tachihara, Motoko ; Hata, Akito ; Tokito, Takaaki...
JTO Clinical and Research Reports.  4 (2023)  10 - p. 100569 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Brigatinib in Japanese patients with ALK‐positive non‐small..:

Yoshida, Tatsuya ; Kumagai, Toru ; Toyozawa, Ryo...
Cancer Science.  114 (2023)  9 - p. 3698-3707 , 2023
Link: https://doi.org/10.1111/..
 
?
6

Phase 1 study of DS‐1205c combined with gefitinib for EGFR ..:

Goto, Koichi ; Shiraishi, Yoshimasa ; Murakami, Haruyasu...
Cancer Medicine.  12 (2023)  6 - p. 7090-7104 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Phase II study of atezolizumab with bevacizumab for non-squ..:

Seto, Takashi ; Nosaki, Kaname ; Shimokawa, Mototsugu...
Journal for ImmunoTherapy of Cancer.  10 (2022)  2 - p. e004025 , 2022
Link: https://doi.org/10.1136/..
 
?
8

Nazartinib for treatment-naive EGFR-mutant non−small cell l..:

Tan, Daniel S.W. ; Kim, Sang-We ; Ponce Aix, Santiago...
European Journal of Cancer.  172 (2022)  - p. 276-286 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Artificial intelligence-derived gut microbiome as a predict..:

Shoji, Fumihiro ; Yamashita, Takanori ; Kinoshita, Fumihiko...
BMJ Open.  12 (2022)  6 - p. e061674 , 2022
Link: https://doi.org/10.1136/..
 
?
10

Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Ve..:

Kenmotsu, Hirotsugu ; Wakuda, Kazushige ; Mori, Keita...
Journal of Thoracic Oncology.  17 (2022)  9 - p. 1098-1108 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Case report: Success of tepotinib therapy in overcoming res..:

Takamori, Shinkichi ; Seto, Takashi ; Yamaguchi, Masafumi...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Necitumumab plus gemcitabine and cisplatin in previously tr..:

Kinoshita, Fumihiko ; Oku, Yuka ; Takamori, Shinkichi...
Investigational New Drugs.  , 2022
Link: https://doi.org/10.1007/..
 
?
13

Management of Peripheral Edema in Patients with MET Exon 14..:

Nishio, Makoto ; Kato, Terufumi ; Toyozawa, Ryo.
Targeted Oncology.  17 (2022)  5 - p. 597-604 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Brigatinib in Japanese Patients With ALK-Positive NSCLC Pre..:

Nishio, Makoto ; Yoshida, Tatsuya ; Kumagai, Toru...
Journal of Thoracic Oncology.  16 (2021)  3 - p. 452-463 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Clinical utility of pretreatment Glasgow prognostic score i..:

Takamori, Shinkichi ; Takada, Kazuki ; Shimokawa, Mototsugu...
Lung Cancer.  152 (2021)  - p. 27-33 , 2021
Link: https://doi.org/10.1016/..
 
1-15